2019
DOI: 10.1016/j.jcv.2019.01.012
|View full text |Cite
|
Sign up to set email alerts
|

A pan-genotypic Hepatitis C Virus NS5A amplification method for reliable genotyping and resistance testing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
3

Relationship

3
4

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 39 publications
0
10
0
Order By: Relevance
“…RNA extraction and reverse transcription were carried out as previously described [2]. DNA amplification and sequencing on the Oxford Nanopore platform were carried out according to the Artic protocol [3,4] (Supplementary Text), yielding between 31 and 582 Mb of raw sequencing data per sample (Supplementary Table S1).…”
Section: Severe Acute Respiratory Syndrome Coronavirus 2 Genome Sequencingmentioning
confidence: 99%
“…RNA extraction and reverse transcription were carried out as previously described [2]. DNA amplification and sequencing on the Oxford Nanopore platform were carried out according to the Artic protocol [3,4] (Supplementary Text), yielding between 31 and 582 Mb of raw sequencing data per sample (Supplementary Table S1).…”
Section: Severe Acute Respiratory Syndrome Coronavirus 2 Genome Sequencingmentioning
confidence: 99%
“…55 SARS-CoV-2 isolate samples, 10 directly linked to the Heinsberg outbreak (obtained from medical practices in the Heinsberg district or from residents of Heinsberg district patients treated at Düsseldorf University Hospital) and 45 from the city of Düsseldorf and surrounding districts, were acquired from diagnostic swabs sent to the Institute of Virology at Düsseldorf University Hospital. RNA extraction and reverse transcription were carried out as previously described 4 . DNA amplification and sequencing on the Oxford Nanopore platform were carried out according to the Artic protocol 5,6 (Supplementary Text), yielding between 31 and 582Mb of raw sequencing data per sample (Supplementary Table S1).…”
Section: Sars-cov-2 Genome Sequencingmentioning
confidence: 99%
“…Of the NS5B positive samples, the vast majority were successfully amplified using in-house genotype specific NS5a primer sets. Recent studies independently arrived at comparable pan-genotypic NS5A primer sets that target similar conserved genomic regions, but also employing additional measures to improve amplification success, such as inosine degeneracy and utilising higher input serum and RNA [45,46]. However, the additional nested strategy employed in one method would necessitate an additional level of expertise in molecular contamination control, potentially adding further logistical challenges in most settings [45].…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies independently arrived at comparable pan-genotypic NS5A primer sets that target similar conserved genomic regions, but also employing additional measures to improve amplification success, such as inosine degeneracy and utilising higher input serum and RNA [45,46]. However, the additional nested strategy employed in one method would necessitate an additional level of expertise in molecular contamination control, potentially adding further logistical challenges in most settings [45]. In general, these simple Sanger-based sequencing and subtyping pipelines should be easily deployable in most resource-poor settings [44].…”
Section: Discussionmentioning
confidence: 99%